Bayer files lawsuit against Johnson & Johnson, Janssen Biotech

Group 1 - Bayer has filed a lawsuit in a New York court against Johnson & Johnson and Janssen Biotech Inc concerning its Nubeqa prostate cancer drug [1] - The lawsuit indicates ongoing legal disputes in the pharmaceutical industry, particularly regarding drug patents and market competition [1] - Bayer is a German pharmaceutical and chemical company, while Johnson & Johnson is a major player in the healthcare sector [1][3] Group 2 - The lawsuit reflects Bayer's strategic actions to protect its product offerings and market position in the oncology sector [1] - Johnson & Johnson and its subsidiary Janssen Biotech Inc are involved in the litigation, highlighting the competitive landscape in the pharmaceutical market [1][3] - The case may have implications for future drug development and patent rights within the industry [1]